Departments and Services | For Patients | Research & Trials | Education | Find a Doctor

Division of Infectious Disease
Division of Infections Disease
Fellowship Program
Clinical Programs
Penn CDC Prevention Epicenters Program
Clinical Trials
Botswana-UPenn Partnership
Adjunct Faculty
Administrative Contacts
Outpatient Clinics


faculty photo

Cheryl Jo White, MD

Adjunct Assistant Professor of Medicine
Department: Medicine

Contact information
Consultant for Research & Development
Infectious Diseases
1007 Stonebridge Road
Lower Gwynedd, PA 19002
BA (Microbiology)
University of Texas, Austin, 1975.
Baylor College of Medicine, 1979.
Post-Graduate Training
Internship & Residency, Baptist Hospital, Bowman Gray School of Medicine, Winston-Salem, North Carolina, 1979-1982.
Fellowship Infectious Diseases, National Institutes of Health, NIAID, Bethesda, MD, 1983-1986.
American Board of Internal Medicine, 1982.
American Board of Infectious Diseases, 1986.
Permanent link
> Perelman School of Medicine   > Faculty   > Details

Selected Publications

Hennessey, J.P., Schmidt, C., White, C.J., Ibrahim, A., Filler, S., Fu, Y., Yeaman, M., Edwards, J.E.: First-in-man clinical evaluation of NDV-3: safety & immunogenicity of a vaccine to prevent disease caused by Candida spand Staphylococcus aureus. 51st ICAAC Chicago September 2011 Notes: Poster Presentation.

Neuzil K, Ortiz J, Englund J, White C: Maternal immunization landscape analysis. Contract No. 17868 September 2010.

Report of an independent expert panel: Analysis of the impact of a new EDCTP. Impact Assessment Report on EDCTP September 2010 Notes:

Para Michael F, Schouten Jeff, Rosenkranz Susan L, Yu Song, Weiner David, Tebas Pablo, White C Jo, Reeds Dominic, Lertora Juan, Patterson Kristine B, Daar Eric S, Cavert Winston, Brizz Barbara, : Phase I/II trial of the anti-HIV activity of mifepristone in HIV-infected subjects ACTG 5200. Journal of acquired immune deficiency syndromes (1999) 53(4): 491-5, Apr 2010.

Hokey D, Laddy D, White C, Weiner D: Influenza vaccines: challenges and opportunities. Avian Influenza: Etiology, Pathogenesis & Interventions 2010.

Muthumani, K., Choo, A.Y., Fagone, P., Chung, C.W., Kawalekar, O.U., Sardesai, N., Kimm, J.J., White, J., Weiner, D.B.: Effect of novel immune modulator agent VGX-1027 on inflammatory cytokine production from Th-17 cells. Joint Annual Meeting of the International Cytokine Society, the International Society for Interferon and Cytokine Research and the Society of Leukocyte Biology, Vancouver, Canada October 2009 Notes: Poster Presentation.

Lee, J., Steel, L., Kahn, A., Dankert, M., Draghia-Akli, R., Sardesai, N., White, C: Tolerability of electroporation by CELLECTRA device in healthy volunteers. DNA Vaccine Meeting, Las Vegas, NV December 2008 Notes: Poster Presentation.

Trollfors, B, Berger J, Bergfors, E, Knuttson, N, Sundh, V, Lagergard, T, Lind-Brandberg L, Zackrisson, G, White, J, Fusco, J, Robbins, J: Mass vaccination of children with pertussis toxoid-decreased incidence in both vaccinated and nonvaccinated persons. Clin Inf Dis 33(7): 1004-1010, 2001.

Shinefield, H, Black, S, Staehle, B, Adelman, T, Ensor, K, Ngai, A, White, CJ, Bird, S, Matthews, H, Kuter, B: Safety, tolerability and immuogenicity of concomitant injections in separate locations of M-M-R II, VARIVAX and TETRAMUNE in healthy children vs. concomitant injection of M-M-R II and TETRAMUNE followed six weeks later by VARIVAX. Ped Inf Dis J 17(11): 980-985, Nov 1998.

Rothestein, EP, Bernstein, HH, Ngai, AL, Choi, I, White, CJ: Dose titration study of Oka/Merck varicella vaccine (VARIVAX) in healthy children. J Inf Dis 175(2): 444-447, 1997.

back to top
Last updated: 02/08/2013
The Trustees of the University of Pennsylvania